1a4k:B (GLY8) to (SER112) DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
4gxu:N (LEU4) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxu:P (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxu:R (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxu:T (PRO8) to (THR105) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxu:X (LEU4) to (THR105) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxv:M (SER9) to (THR105) CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
1nl0:L (SER9) to (THR105) CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY, 10C12 | IMMUNE SYSTEM, ANTIBODY, GLA DOMAIN
4hj0:D (PRO8) to (VAL109) CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION | GLUCAGON RECEPTOR SUB-FAMILY RECOGNITION FOLD, IMMUNE SYSTEM
1bjm:A (PRO8) to (VAL109) LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4 | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
1bjm:B (PRO8) to (VAL109) LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4 | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
3t0v:A (PRO8) to (VAL106) UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL | IMMUNOGLOBULIN FOLD, FLUOROGEN ACTIVATION, DIMETHYLINDOLE RED, DYE- BINDING PROTEIN
3t0x:B (PRO8) to (VAL106) FLUOROGEN ACTIVATING PROTEIN M8VLA4(S55P) IN COMPLEX WITH DIMETHYLINDOLE RED | IMMUNOGLOBULIN FOLD, FLUOROGEN ACTIVATION, DIMETHYLINDOLE RED, DYE- BINDING PROTEIN
3ghe:L (ALA8) to (VAL106) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
3tje:L (SER9) to (VAL109) CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09 | AGONISTIC ANTIBODY, FAB FRAGMENT, ANTIBODY-RECEPTOR COMPLEX, TUMOR NECROSIS FACTOR RECEPTOR, CYSTEINE-RICH DOMAIN, FAS, IMMUNE SYSTEM
2rhe:A (PRO8) to (GLY111) STRUCTURE OF A NOVEL BENCE-JONES PROTEIN (RHE) FRAGMENT AT 1.6 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
4yjz:L (LEU8) to (LEU110) HUMAN ANTIBODY H2526 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006 | INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3u36:L (SER9) to (THR105) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3u36:B (SER9) to (THR105) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3u36:D (SER9) to (THR105) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3u36:F (SER9) to (THR105) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3hae:N (SER9) to (VAL108) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4k3d:L (SER8) to (VAL106) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
4k3d:M (SER8) to (GLY107) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
4k3e:L (SER8) to (GLY107) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN; CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
3ujj:L (SER9) to (VAL106) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE | IG DOMAINS, ANTIBODY FAB, ANTIGEN BINDING, THE THIRD VARIABLE REGION OF HIV-1 GP120, IMMUNE SYSTEM
2fb4:L (PRO8) to (VAL107) DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN) | IMMUNOGLOBULIN
1rzf:L (PRO9) to (VAL106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51 | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
3iyw:L (SER9) to (VAL109) WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU) | VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS
3iyw:M (SER9) to (VAL109) WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU) | VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS
4m6m:L (SER9) to (VAL110) CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
5acl:A (PRO8) to (VAL109) MCG IMMUNOGLOBULIN VARIABLE DOMAIN WITH SULFASALAZINE | IMMUNE SYSTEM, MCG, IMMUNOGLOBULIN VARIABLE DOMAIN, METHYLENE BLUE
5acm:A (PRO8) to (VAL109) MCG IMMUNOGLOBULIN VARIABLE DOMAIN WITH METHYLENE BLUE | IMMUNE SYSTEM, MCG, IMMUNOGLOBULIN VARIABLE DOMAIN, METHYLENE BLUE
5alb:L (PRO9) to (VAL106) TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR | IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG
5awn:L (SER9) to (SER105) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB | HIV-1, ENV, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
2jb6:L (ALA8) to (VAL110) FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2 | CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM
2xwt:B (PRO8) to (VAL106) CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY | SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX, GPCR, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR-AUTOANTIBODY COMPLEX
5c0s:L (PRO8) to (VAL106) CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261 | HEMAGGLUTININ, IMMUNOGEN, TRIMER, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4nzt:L (ALA9) to (VAL106) CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB | LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
5cba:B (ALA8) to (VAL106) 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13 | ANTI-CXCL13, CXCL13, SCFV, IMMUNE SYSTEM
2ykl:L (SER10) to (ILE106) STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE | IMMUNE SYSTEM, MONOCLONAL ANTIBODIES, ANTI-SMOKING VACCINE
5cck:L (SER9) to (VAL106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB | HIV-1, ENV, BNAB, ANTIBODY, IMMUNE SYSTEM
4ocr:L (SER9) to (VAL106) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.01, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4od2:A (PRO7) to (THR105) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-DR5 ANTIBODY BOUND TO DR5 | IGG, FAB FRAGMENT,CRD,TNFSF, APOPTOSIS-IMMUNE SYSTEM COMPLEX
3kdm:A (ALA8) to (THR113) CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE | IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN FAB FRAGMENT, ANTI-STEROID
4ot1:L (PRO8) to (VAL108) STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1 | IMMUNOGLOBULIN, PH DOMAIN, ANTIBODY-ANTIGEN RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1mcd:A (PRO8) to (VAL109) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
5dur:L (SER9) to (GLY113) INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4 | INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM
4q2z:L (SER9) to (VAL106) FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE356, FROM A NON-HUMAN PRIMATE | FAB FRAGMENT, HIV VIRAL ENVELOPE GLYCOPROTEIN NEUTRALIZATION, IMMUNE SYSTEM
3lrg:A (SER9) to (ALA112) STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN | HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3lrg:B (SER9) to (VAL109) STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN | HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
2a9n:L (SER9) to (VAL147) A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX | IMMUNOGLOBULIN, FLUORESCEIN, SCFV, IMMUNE SYSTEM
2a9n:M (SER9) to (VAL147) A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX | IMMUNOGLOBULIN, FLUORESCEIN, SCFV, IMMUNE SYSTEM
3mlw:L (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlw:M (PRO8) to (THR105) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mme:L (ALA8) to (VAL105) STRUCTURE AND FUNCTIONAL DISSECTION OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
3bjl:A (PRO8) to (VAL109) LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
5f6h:L (PRO8) to (GLY111) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5f6h:N (PRO8) to (GLY111) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5f6j:A (PRO8) to (VAL109) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE | FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX
5f6j:F (PRO8) to (VAL109) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE | FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX
4buh:A (PRO149) to (VAL250) HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV | IMMUNE SYSTEM, ANTIBODY, ALLERGEN
3n9g:L (SER9) to (VAL109) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354 | FAB FRAGMENT, HUMAN NEUTRALIZING ANTIBODY, MAB CR4354, IMMUNE SYSTEM, ANTI-WEST NILE VIRUS
4rfe:L (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4rfe:D (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4rfe:F (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4rfn:L (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48 | HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4rfn:C (PRO8) to (VAL106) CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48 | HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3nps:C (SER9) to (VAL106) CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4 | HYDROLASE, ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME-INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE, HYDROLASE - IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
3d69:L (SER9) to (VAL106) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12 | ANTICOAGULANT, 10C12, FACTOR IX, GLA DOMAIN, IMMUNE SYSTEM
4tsb:L (SER9) to (GLY107) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
5grj:L (LEU4) to (VAL109) CRYSTAL STRUCTURE OF HUMAN PD-L1 WITH MONOCLONAL ANTIBODY AVELUMAB | PD-L1, AVELUMAB, MONOCLONAL ANTIBODY, TUMOR IMMUNOTHEPAPY, IMMUNE SYSTEM
4ut7:L (VAL8) to (VAL106) CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 | IMMUNE SYSTEM, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, SCFV FRAGMENT
4utb:L (VAL8) to (VAL106) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT
4utb:M (VAL8) to (VAL106) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT
4evn:B (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:D (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:F (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:H (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:J (PRO8) to (GLY112) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:L (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:N (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:P (PRO8) to (VAL110) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
5j74:A (SER151) to (VAL251) FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P | FLUOROGEN ACTIVATING PROTEIN DRUG DISCOVERY BIOSENSOR PROTEIN TRAFFICKING, PROTEIN BINDING, IMMUNE SYSTEM
5j74:B (SER151) to (VAL251) FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P | FLUOROGEN ACTIVATING PROTEIN DRUG DISCOVERY BIOSENSOR PROTEIN TRAFFICKING, PROTEIN BINDING, IMMUNE SYSTEM
5j75:A (SER151) to (VAL251) FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342 | FLUOROGEN ACTIVATING PROTEIN, DRUG DISCOVERY, BIOSENSOR, PROTEIN TRAFFICKING, IMMUNE SYSTEM
5j75:B (SER151) to (VAL251) FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342 | FLUOROGEN ACTIVATING PROTEIN, DRUG DISCOVERY, BIOSENSOR, PROTEIN TRAFFICKING, IMMUNE SYSTEM
4fqh:L (ALA9) to (LEU106) CRYSTAL STRUCTURE OF FAB CR9114 | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM
4fqh:B (ALA9) to (VAL106) CRYSTAL STRUCTURE OF FAB CR9114 | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM
4fqi:L (ALA9) to (VAL106) CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H5N1 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqj:L (LEU4) to (VAL106) INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX | MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqk:F (LEU4) to (VAL106) INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX | ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4fqk:L (LEU4) to (VAL106) INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX | ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4fqv:L (ALA9) to (VAL106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqv:M (ALA9) to (VAL106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqv:N (ALA9) to (VAL106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqy:L (ALA9) to (VAL106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5lcv:L (VAL8) to (VAL106) STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA VIRUS, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3g04:A (PRO8) to (VAL106) CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY | TSH RECEPTOR, GPCR, THYROID, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR- AUTOANTIBODY COMPLEX, IMMUNE SYSTEM
4y5v:B (ALA8) to (LEU110) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4y5v:H (ALA8) to (VAL109) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4y5x:K (PRO8) to (ALA111) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR
3h42:L (SER9) to (VAL110) CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY | HYDROLASE, PROTEIN FAB COMPLEX, AUTOCATALYTIC CLEAVAGE, CHOLESTEROL METABOLISM, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, LIPID METABOLISM, PHOSPHOPROTEIN, PROTEASE, SECRETED, SERINE PROTEASE, STEROID METABOLISM, ZYMOGEN, HYDROLASE-IMMUNE SYSTEM COMPLEX
3ux9:B (SER11) to (VAL111) STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS | FIVE HELICES, LONG LOOP CONNECTING HELIX, HYDROPHOBIC INTERACTIONS, CYTOKINE-IMMUNE SYSTEM COMPLEX
3ux9:D (SER11) to (VAL111) STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS | FIVE HELICES, LONG LOOP CONNECTING HELIX, HYDROPHOBIC INTERACTIONS, CYTOKINE-IMMUNE SYSTEM COMPLEX
2yk1:L (PRO9) to (GLY107) STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE | IMMUNE SYSTEM, MONOCLONAL ANTIBODIES, ANTI-SMOKING VACCINE
5cgy:L (PRO8) to (VAL110) FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21 | ANTIBODY, FAB, IMMUNE SYSTEM
5cjs:E (ALA9) to (VAL106) CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114 | HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4py8:I (GLY10) to (SER121) CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ | HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, MEMBRANE FUSION, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2a9m:L (SER9) to (VAL147) STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM | IMMUNOGLOBULINS, FLUORESCEIN, IMMUNE SYSTEM
3mlx:M (SER9) to (VAL106) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4tsc:L (PRO8) to (GLY107) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
4ttd:D (SER9) to (VAL106) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | IMMUNE SYSTEM, AFFINITY MATURATION
4d9l:L (SER9) to (VAL106) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4d9l:M (SER9) to (VAL106) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4d9l:O (SER9) to (VAL106) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM